12:00 AM
 | 
Feb 04, 2013
 |  BC Week In Review  |  Financial News  |  Other Financial News

Pharmaxis financial update

Pharmaxis said NovaQuest Pharma Opportunities Fund III agreed to invest up to $40 million to support the development of Bronchitol mannitol in the EU and U.S....

Read the full 120 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >